Quantbot Technologies’s Axsome Therapeutics AXSM Stock Holding History

Quantbot Technologies’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,396	Closed	-$3.54M	–	1713
2025 Q4	$3.54M	Buy	19,396 +8,519	+78%	+$1.19M	0.12%	265
2025 Q3	$1.32M	Sell	10,877 -7,717	-42%	-$869K	0.04%	678
2025 Q2	$1.94M	Buy	18,594 +18,330	+6,943%	+$1.94M	0.05%	532
2025 Q1	$30.8K	Buy	+264	New	+$30.1K	﹤0.01%	1351
2022 Q3	–	Sell	-8,178	Closed	-$313K	–	1593
2022 Q2	$313K	Buy	8,178 +4,222	+107%	+$134K	0.03%	759
2022 Q1	$163K	Buy	+3,956	New	+$123K	0.01%	923
2020 Q1	–	Sell	-356	Closed	-$36K	–	916
2019 Q4	$36K	Sell	356 -2,970	-89%	-$120K	﹤0.01%	994
2019 Q3	$67K	Buy	3,326 +770	+30%	+$19.8K	0.01%	916
2019 Q2	$65K	Buy	+2,556	New	+$51.2K	0.01%	847

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantbot Technologies's AXSM Position: Q1 2026 in Review

Quantbot Technologies sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 19,396 shares — an estimated $3.54M sold.

Quantbot Technologies first reported a position in AXSM in Q2 2019 and held it in 9 quarters. The position peaked at $3.54M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

Quantbot Technologies reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
Quantbot Technologies sold 19,396 Axsome Therapeutics shares in Q1 2026, an estimated $3.54M.
Quantbot Technologies first reported a position in Axsome Therapeutics in Q2 2019 and held it in 9 quarters.
Quantbot Technologies's Axsome Therapeutics position peaked at $3.54M in Q4 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.